{"name":"BioSig Technologies","slug":"biosig","ticker":"BSGM","exchange":"NASDAQ","domain":"biosigtech.com","description":"BioSig Technologies is a medical device company focused on cardiac electrophysiology. The company's flagship product is the PURE EP System, a signal processing technology designed to improve the accuracy and efficiency of electrophysiology procedures. BioSig Technologies is positioned to capitalize on the growing demand for innovative electrophysiology solutions. The company's technology has the potential to disrupt the traditional signal processing market and provide a new standard for electrophysiology procedures.","hq":"Minneapolis, MN","founded":0,"employees":"","ceo":"Kenneth Londoner","sector":"Medical Devices — Cardiac Electrophysiology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$28M","metrics":{"revenue":18000,"revenueGrowth":-93.7,"grossMargin":0,"rdSpend":832000,"netIncome":-10330000,"cash":842000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-14","type":"deal","headline":"BioSig Technologies Announces Exclusive Distribution Agreement with Medtronic","summary":"BioSig Technologies has entered into an exclusive distribution agreement with Medtronic to distribute the PURE EP System in the United States.","drugName":"","sentiment":"positive"},{"date":"2022-11-14","type":"earnings","headline":"BioSig Technologies Reports Third Quarter 2022 Financial Results","summary":"BioSig Technologies reported its third quarter 2022 financial results, with revenue of $0.4 million and a net loss of $3.4 million.","drugName":"","sentiment":"neutral"}],"realNews":[{"date":"2026-03-31","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOTm83S1VnTkp4bE1uZm1TYUpZMEVkUkRBQi1OeGE0T1NvTGRjLTg1WTh3dG1VTklDeERjQV82ci1PSGNzVlAwSUxzbGNlQmY5a2FiVTNncXc3M0RHV21nUUIzUDhlQ3pJaEZXZkZjWEZhaGN4U081SGZUNEY1TlAwTVkzOUhkSjQ0eVJEcWx4ZURlTDFyWVVwS1RTLUhhUThwREg5NzhBc0dNQ3pBYnBpQ1UyZzN1QTI5REtz?oc=5","date":"2025-09-10","type":"pipeline","source":"Stock Titan","summary":"Major Nasdaq Rebrand: BioSig Technologies Transforms to Streamex Corp with New Trading Symbol STEX - Stock Titan","headline":"Major Nasdaq Rebrand: BioSig Technologies Transforms to Streamex Corp with New Trading Symbol STEX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQWXR0bndvWWpLSWdCbjhEVEhHdk1TMGhITjRZcFdPc3hkblM0UWdhV3pneDBwMkJXUVVPcHNLQUZPNUZoZmtuLVZGMG9xSThYMFhjS1U1dWVLN2FMQktuQXdQZWhvY1ZnRHRtcXpnZGpCVVlLUXR4a2U3Z1V2Wk5taExXX1FCckt2a0RBQUhVc1RRTlk?oc=5","date":"2025-08-16","type":"pipeline","source":"Seeking Alpha","summary":"BioSig Technologies Stock: Now A Gold Tokenization Play (NASDAQ:BSGM) - Seeking Alpha","headline":"BioSig Technologies Stock: Now A Gold Tokenization Play (NASDAQ:BSGM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQM1dPaGlwS3ZHdG1PTlhOWkJMeU92WFhpN0QtdHhuS1ppMkROc040X1BYYnc3SlJEVGtFTzE0ZktDY01MamlJSTFrRzRFUzltRVc4aHI0THF4Wlc2U0htOUY5U2J1ektiWVRNVW9tWlo3VW9kTmFrbXFlTmVuYVFMTnBqWnZ6bld1MkxNQWZGb01URnB3amI4OQ?oc=5","date":"2025-07-28","type":"deal","source":"The Motley Fool","summary":"Here's 1 New Billion-Dollar Reason to Buy Solana And Never Look Back - The Motley Fool","headline":"Here's 1 New Billion-Dollar Reason to Buy Solana And Never Look Back","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQQ2JQUXFYNXlsYm1OaXYtQnpRb2Z6S2otRlcyRWRZbURTMmxMTVItMUFQcEdidkZXOW5FaExqOXRuUy1sbkdNNGpSUnlzX1Vod3JDaEVEX09zN0Q4WHpOZXNxbUFRR08zNDZxQ1pxYkpnXzlFWHlCYm02UUFLcFZSc3hOM01TSFlPSXk5WmtDbUlhUXFWMVQyRFFEOC1hNmd6b1NVWGg2VGM5NDBzNEIwOA?oc=5","date":"2025-07-21","type":"pipeline","source":"Streetwise Reports","summary":"BSGM Announces Major Financing for Gold-Backed Tokens - Streetwise Reports","headline":"BSGM Announces Major Financing for Gold-Backed Tokens","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxPQVlyMmpzRWJnemtQUFFqYWFGaGFFclcyc0oxaDdJTW1ZVlNXVHctS3BxTVhORFVwNEZFbmNLN0hSYnNPRkxnbngwNkh1LUV6TWRQcldyRjJoVmVMcEdHVldSYW5sQlFFWFduQlc1Qy1rWDZzX05fM0M3Q0t5M2E0dEJsR1puQUxMVl9KbVVnLXljLTdNMnpZU1prdk9EeU9JVmhPSGNVYmFfZ0lMMkhYcWhtNWx4V3pGeUROMF9OVjBxYVJuMjB0SV93YjFqRXZ2aTJOQmhhWWV0NW9rbHJwVlNJbmtNTGpQRkcwR0lUb2xNekIxLXA1bDdRQzlCRUZseEE?oc=5","date":"2025-07-14","type":"deal","source":"Business Wire","summary":"BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations - Business Wire","headline":"BSGM Engages CXG to Acquire FINRA/SEC-Registered Broker-Dealer to Expand Publicly Traded RWA Tokenization Operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQc3p6UW5HZTFWMzdpajVIQi1FVWxfcWw4SVVERFlFdklKcV93OHFuQ05lSW9abDZfVHRfbnk0T2ZvU0tyTF9ZQTdlUjJ3NUpoNFlVVHpwNEVlT3hPWi1Yci0tUS02QnVBNExQdDFiVzU0UUdDZEpfclA2aUpXZ0JjYi1Ga0hjckJsMTFR?oc=5","date":"2024-10-28","type":"pipeline","source":"Moomoo","summary":"Pre Market Ticks. 5:32am 10/28 - Moomoo","headline":"Pre Market Ticks. 5:32am 10/28","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNcFNnWjNaWU5kU3M5b2xadnY5andpZ0YzaTVtNTBDSzNaTEk5Y0w3WEpNeU9RNVE4LXpuSG1kbVE4NFA2R3JyVEltOHoxa0gzNHpFLVRGRlVFUkVZdWdvY3hTb3NteWV5dElmd0JGTHQ0eVVkNU9XQmFGNVZ1WVBQcHM2LVQ1dkJKYjlTQnJ6SzdTR0dRbTZ2Q1pxTDhlMnJxLTVfOWRiRGl2cmxWN2dGazI3MnJlUE40a2pJQ0wxek5YdjJ6VnBQQ1FFSXZUeWgweXQ4Mmxn?oc=5","date":"2022-03-16","type":"pipeline","source":"proactiveinvestors.com","summary":"BioSig Technologies appoints John Sieckhaus as chief operating officer - proactiveinvestors.com","headline":"BioSig Technologies appoints John Sieckhaus as chief operating officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Boston Scientific","Medtronic","Abbott Laboratories"],"therapeuticFocus":["Cardiac Electrophysiology"],"financials":{"source":"sec_edgar","revenue":18000,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":18000,"period":"2023-12-31"},{"value":286000,"period":"2022-12-31"},{"value":286000,"period":"2022-12-31"},{"value":441000,"period":"2021-12-31"},{"value":441000,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":832000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-10330000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":842000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}